These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
413 related articles for article (PubMed ID: 26412163)
1. Prognostic factors in necrotizing soft-tissue infections (NSTI): A cohort study. Hua C; Sbidian E; Hemery F; Decousser JW; Bosc R; Amathieu R; Rahmouni A; Wolkenstein P; Valeyrie-Allanore L; Brun-Buisson C; de Prost N; Chosidow O J Am Acad Dermatol; 2015 Dec; 73(6):1006-12.e8. PubMed ID: 26412163 [TBL] [Abstract][Full Text] [Related]
2. Immunocompromised status in patients with necrotizing soft-tissue infection. Keung EZ; Liu X; Nuzhad A; Adams C; Ashley SW; Askari R JAMA Surg; 2013 May; 148(5):419-26. PubMed ID: 23677405 [TBL] [Abstract][Full Text] [Related]
3. Development and validation of a necrotizing soft-tissue infection mortality risk calculator using NSQIP. Faraklas I; Stoddard GJ; Neumayer LA; Cochran A J Am Coll Surg; 2013 Jul; 217(1):153-160.e3; discussion 160-1. PubMed ID: 23628224 [TBL] [Abstract][Full Text] [Related]
4. Mortality of necrotizing fasciitis: relative influence of individual and hospital-level factors, a nationwide multilevel study, France, 2007-12. Audureau E; Hua C; de Prost N; Hemery F; Decousser JW; Bosc R; Lepeule R; Chosidow O; Sbidian E; Br J Dermatol; 2017 Dec; 177(6):1575-1582. PubMed ID: 28452064 [TBL] [Abstract][Full Text] [Related]
5. Necrotizing soft tissue infections: improved outcomes with modern care. Tillou A; St Hill CR; Brown C; Velmahos G Am Surg; 2004 Oct; 70(10):841-4. PubMed ID: 15534961 [TBL] [Abstract][Full Text] [Related]
6. Necrotizing Soft Tissue Infections at a Tertiary Referral Hospital in Rwanda: Epidemiology and Risk Factors for Mortality. Mpirimbanyi C; Rickard J; Furaha C; Ntirenganya F World J Surg; 2018 Aug; 42(8):2314-2320. PubMed ID: 29417246 [TBL] [Abstract][Full Text] [Related]
7. Biomarkers of Necrotising Soft Tissue Infections Aspects of the Innate Immune Response. Hansen MB Dan Med J; 2017 Jul; 64(7):. PubMed ID: 28673381 [TBL] [Abstract][Full Text] [Related]
8. Sweet and Sour: Impact of Early Glycemic Control on Outcomes in Necrotizing Soft-Tissue Infections. Beauchamp LC; Mostafavifar LG; Evans DC; Gerlach AT Surg Infect (Larchmt); 2019; 20(4):305-310. PubMed ID: 30716012 [No Abstract] [Full Text] [Related]
9. Characteristics and differences in necrotizing fasciitis and gas forming myonecrosis: a series of 36 patients. Tilkorn DJ; Citak M; Fehmer T; Ring A; Hauser J; Al Benna S; Steinstraesser L; Roetman B; Steinau HU Scand J Surg; 2012; 101(1):51-5. PubMed ID: 22414469 [TBL] [Abstract][Full Text] [Related]
10. Are we getting necrotizing soft tissue infections right? A 10-year review. Proud D; Bruscino Raiola F; Holden D; Paul E; Capstick R; Khoo A ANZ J Surg; 2014 Jun; 84(6):468-72. PubMed ID: 24164901 [TBL] [Abstract][Full Text] [Related]
11. A Multi-Center Review of Care Patterns and Outcomes in Necrotizing Soft Tissue Infections. Faraklas I; Yang D; Eggerstedt M; Zhai Y; Liebel P; Graves G; Dissanaike S; Mosier M; Cochran A Surg Infect (Larchmt); 2016 Dec; 17(6):773-778. PubMed ID: 27834617 [TBL] [Abstract][Full Text] [Related]
12. Association between adjunct clindamycin and in-hospital mortality in patients with necrotizing soft tissue infection due to group A Streptococcus: a nationwide cohort study. Hamada S; Nakajima M; Kaszynski RH; Otaka S; Goto H; Matsui H; Fushimi K; Yamaguchi Y; Yasunaga H Eur J Clin Microbiol Infect Dis; 2022 Feb; 41(2):263-270. PubMed ID: 34755257 [TBL] [Abstract][Full Text] [Related]
13. Complement Activation Is Associated With Mortality in Patients With Necrotizing Soft-Tissue Infections-A Prospective Observational Study. Kristensen MK; Hansen MB; Madsen MB; Hansen CB; Pilely K; Hyldegaard O; Garred P Front Immunol; 2020; 11():17. PubMed ID: 32082310 [No Abstract] [Full Text] [Related]
14. Epidemiology and Outcomes of Hospitalized Children With Necrotizing Soft-Tissue Infections. Totapally BR Pediatr Infect Dis J; 2017 Jul; 36(7):641-644. PubMed ID: 28005689 [TBL] [Abstract][Full Text] [Related]
15. The microbiology of necrotizing soft tissue infections. Elliott D; Kufera JA; Myers RA Am J Surg; 2000 May; 179(5):361-6. PubMed ID: 10930480 [TBL] [Abstract][Full Text] [Related]
16. Predictors of mortality and limb loss in necrotizing soft tissue infections. Anaya DA; McMahon K; Nathens AB; Sullivan SR; Foy H; Bulger E Arch Surg; 2005 Feb; 140(2):151-7; discussion 158. PubMed ID: 15723996 [TBL] [Abstract][Full Text] [Related]
17. The impact of diabetes in patients with necrotizing soft tissue infections. Kao LS; Knight MT; Lally KP; Mercer DW Surg Infect (Larchmt); 2005; 6(4):427-38. PubMed ID: 16433607 [TBL] [Abstract][Full Text] [Related]
18. Necrotizing soft tissue infections: delayed surgical treatment is associated with increased number of surgical debridements and morbidity. Kobayashi L; Konstantinidis A; Shackelford S; Chan LS; Talving P; Inaba K; Demetriades D J Trauma; 2011 Nov; 71(5):1400-5. PubMed ID: 21768906 [TBL] [Abstract][Full Text] [Related]
19. Can progression of odontogenic infections to cervical necrotizing soft tissue infections be predicted? Zemplenyi K; Lopez B; Sardesai M; Dillon JK Int J Oral Maxillofac Surg; 2017 Feb; 46(2):181-188. PubMed ID: 27756512 [TBL] [Abstract][Full Text] [Related]
20. Pentraxin-3 as a marker of disease severity and risk of death in patients with necrotizing soft tissue infections: a nationwide, prospective, observational study. Hansen MB; Rasmussen LS; Garred P; Bidstrup D; Madsen MB; Hyldegaard O Crit Care; 2016 Feb; 20():40. PubMed ID: 26880104 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]